Latest Capital Markets News

ikeGPS Group reports a robust first half of FY26 with subscription revenue surging 47%, driven by AI innovation and strong market demand. The company reaffirms its FY26 growth targets amid a solid balance sheet and leadership expansion.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

CD Private Equity Fund III reported a $3.02 million net loss for the half-year ending September 2025, driven largely by foreign currency translation losses, yet maintained a 10 cent per unit distribution supported by portfolio realisations and cash management.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Alliance Aviation Services reported record FY25 revenue and flying hours but faces margin pressures from rising costs and a major contract renegotiation. The company’s refreshed leadership is focused on operational improvements and debt reduction in FY26.

BOA Resources has acquired a significant stake in the Neds Creek copper project in Western Australia’s Murchison region, setting the stage for a major exploration push in 2026 focused on the drill-ready Ricci Lee prospect.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

DPM Metals has released a robust feasibility study for its Čoka Rakita gold project in Serbia, confirming strong economics with a $782 million net present value and a 36% internal rate of return at $1,900 per ounce gold. The study highlights increased reserves, low costs, and a clear path to production by 2029.

Redivium Limited has withdrawn its planned European Green Bond issuance amid challenging market conditions and an ongoing ASX suspension, despite securing conditional investor commitments. The company signals a future return to green debt markets when conditions improve.

Redivium Limited is advancing a recapitalisation strategy with Australian investors to meet ASX requirements and resume trading after a prolonged suspension.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

Alicanto Minerals has appointed seasoned resources executive Jeffrey Sansom as CEO, signaling a strategic push to advance its Falun Copper-Gold Project and pursue new acquisitions. The leadership change aligns with the company’s ambitions to enhance shareholder value through disciplined growth.